Nanobiotix S.A. (NBTX)
NASDAQ: NBTX · Real-Time Price · USD
10.20
+0.46 (4.75%)
At close: Sep 17, 2025, 4:00 PM EDT
16.73
+6.53 (63.98%)
After-hours: Sep 17, 2025, 7:59 PM EDT
Nanobiotix Market Cap
Nanobiotix has a market cap or net worth of $517.63 million as of September 17, 2025. Its market cap has increased by 121.74% in one year.
Market Cap
517.63M
Enterprise Value
519.01M
1-Year Change
121.74%
Ranking
Category
Stock Price
$10.20
Market Cap Chart
Since the IPO on November 21, 2016, Nanobiotix's market cap has increased from $249.91M to $517.63M, an increase of 107.12%. That is a compound annual growth rate of 8.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 517.63M | 248.77% |
| Dec 31, 2024 | 148.41M | -57.08% |
| Dec 29, 2023 | 345.77M | 156.45% |
| Dec 30, 2022 | 134.83M | -53.41% |
| Dec 31, 2021 | 289.40M | -50.20% |
| Dec 31, 2020 | 581.15M | 179.88% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Nov 21, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 677.80B |
| Johnson & Johnson | 426.28B |
| AbbVie | 382.57B |
| UnitedHealth Group | 308.32B |
| Novo Nordisk | 248.69B |
| AstraZeneca | 240.71B |
| Novartis AG | 238.00B |
| Abbott Laboratories | 231.53B |